Figure 4From: Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot studyMean platelet-monocyte aggregates during the study period in patients treated with unfractioned heparin (UFH) versus UFH + tirofiban and with or without intra-aortic balloon pump (IABP). Data are shown as mean ± standard deviation. n.s., not significant.Back to article page